Emergence acquires Clinect Healthcare
Emergence has acquired Charlotte-based Clinect Healthcare to speed development of its patient experience and outcomes platform. The deal gives Clinect new capital and operating support as healthcare providers face more pressure to prove clinical results and patient satisfaction.
Why it matters: - Healthcare organizations are under growing pressure to prove the results of care to payers, regulators and employers. - Clinect’s platform helps providers collect patient-reported outcomes inside existing workflows, which can reduce administrative burden while improving quality reporting and follow-up. - Emergence is adding another healthcare software asset to its long-term portfolio and backing Clinect’s next phase of growth.
What happened: - Clinect Healthcare said Tuesday it has been acquired by Emergence, a permanent-capital enterprise backed by The Pritzker Organization. - The deal brings Clinect’s Outcomes Intelligence Platform into Emergence’s healthcare technology portfolio. - Clinect is based in Charlotte, N.C., and was founded in 2012.
The details: - Clinect’s platform captures and acts on more than 600 validated outcome measures. - The system connects with 20-plus practice management and EHR integrations, with the company later citing 50-plus practice management and EHR systems in its background information. - The company’s tools cover digital intake, patient-reported outcomes, patient experience software and reputation management. - Clinect says the platform helps providers document treatment results, support quality reporting and identify patients who may need additional attention. - The company says it will expand investment in data science, AI and interoperability under Emergence ownership. - Clinect also plans to broaden its PM/EHR integrations and accelerate product development for health systems and specialty practices nationwide. - Clinect serves health systems and specialty practices across the U.S.
Between the lines: - The acquisition fits a broader shift in healthcare toward measuring outcomes more continuously and inside the clinical workflow. - Emergence appears to be betting that better data capture, analytics and interoperability can become a stronger selling point as reimbursement models evolve. - The transaction also suggests Clinect may have more room to scale if it can pair its software with additional operating support and capital.
What's next: - Clinect plans to use Emergence’s backing to expand faster and reach more healthcare organizations. - The companies expect continued investment in product development, AI and integration capabilities. - Clinect will keep focusing on helping providers measure both financial and clinical performance.
The bottom line: - Emergence is buying into a healthcare software platform built around outcomes data, and the timing lines up with rising demand for measurable care results.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Today in Healthcare
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.